• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.

作者信息

Tapanainen J, Martikainen H, Voutilainen R, Orava M, Ruokonen A, Rönnberg L

机构信息

Department of Obstetrics and Gynecology, University of Oulu, Finland.

出版信息

Fertil Steril. 1992 Oct;58(4):726-32. doi: 10.1016/s0015-0282(16)55319-9.

DOI:10.1016/s0015-0282(16)55319-9
PMID:1426317
Abstract

OBJECTIVE

To study the effect of growth hormone (GH) in combination with an ultrashort-term gonadotropin-releasing hormone analogue/human menopausal gonadotropin (hMG)/human chorionic gonadotropin (hCG) regimen in ovarian hyperstimulation for in vitro fertilization (IVF).

DESIGN

Prospective randomized placebo-controlled study.

SETTING

University-based IVF program.

PATIENTS

Fifty-four normally cycling women (27 control and 27 GH-treated) participated in this study.

INTERVENTIONS

Human recombinant GH (24 IU)/placebo was given intramuscularly on alternate days starting on cycle day 4 until the day of last hMG injection.

RESULTS

Serum estradiol (E2) and progesterone (P) concentrations were slightly lower in the GH group than in the placebo group on the day of hCG injection and 1 day thereafter (P < 0.01 to 0.001). Serum luteinizing hormone, follicle-stimulating hormone, prolactin, testosterone (T), and sex hormone-binding globulin did not differ between the groups. The follicular fluid (FF) concentration of T was higher in the GH group than in the placebo group (15.9 +/- 6.0 nmol/L versus 10.2 +/- 4.9 nmol/L, P < 0.005), and no differences were observed in the FF concentrations of E2, P, and insulin-like growth factor I between the groups. In granulosa cells isolated from patients who received GH treatment, the levels of 3 beta-hydroxysteroid dehydrogenase and aromatase messenger ribonucleic acid were significantly higher than in the patients receiving placebo. The number of hMG ampules needed for follicular development and the number of follicles and oocytes recovered were similar in both groups.

CONCLUSIONS

These results indicate that GH administration modifies ovarian steroidogenic response to gonadotropins in IVF patients, suggesting a role for GH in the regulation of human ovarian function.

摘要

相似文献

1
Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.
Fertil Steril. 1992 Oct;58(4):726-32. doi: 10.1016/s0015-0282(16)55319-9.
2
Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.在接受控制性卵巢过度刺激的女性中,促性腺激素释放激素拮抗剂与激动剂给药的比较:周期表现及颗粒黄体细胞的体外类固醇生成
Am J Obstet Gynecol. 1995 May;172(5):1518-25. doi: 10.1016/0002-9378(95)90490-5.
3
The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.补充生长激素对体外受精结局的影响:一项前瞻性随机安慰剂对照双盲研究。
Fertil Steril. 1992 Sep;58(3):575-80. doi: 10.1016/s0015-0282(16)55266-2.
4
Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization.生长激素对体外受精前接受促性腺激素治疗患者卵泡液雄激素水平的影响。
Eur J Endocrinol. 1996 Feb;134(2):190-6. doi: 10.1530/eje.0.1340190.
5
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
6
Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.用于体外受精的促性腺激素刺激会显著改变卵泡液中的激素环境:自然周期体外受精与传统体外受精的比较研究。
Hum Reprod. 2014 May;29(5):1049-57. doi: 10.1093/humrep/deu044. Epub 2014 Mar 6.
7
Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.使用促性腺激素释放激素激动剂进行短期或长期治疗后体外受精期间的血清和卵泡液激素水平
Fertil Steril. 2001 Apr;75(4):694-9. doi: 10.1016/s0015-0282(01)01676-4.
8
Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.卵泡发育后向猕猴注射人促黄体生成素(hLH):对灵长类卵泡排卵变化所需促黄体生成素激增进行进一步滴定。
J Clin Endocrinol Metab. 1992 Aug;75(2):502-7. doi: 10.1210/jcem.75.2.1639951.
9
Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.绝经前垂体与卵巢的关系。I. 血清卵泡刺激素、黄体生成素、催乳素、雌二醇和孕酮水平的横断面研究。
Am J Obstet Gynecol. 1977 Nov 1;129(5):557-64.
10
The effect of growth hormone on granulosa cell function during in-vitro fertilization.生长激素对体外受精期间颗粒细胞功能的影响。
Hum Reprod. 1993 Oct;8(10):1588-92. doi: 10.1093/oxfordjournals.humrep.a137896.

引用本文的文献

1
Empirical use of growth hormone in IVF is useless: the largest randomized controlled trial.在体外受精中经验性使用生长激素并无用处:最大规模的随机对照试验
Hum Reprod. 2025 Jan 1;40(1):77-84. doi: 10.1093/humrep/deae251.
2
Growth hormone in fertility and infertility: Mechanisms of action and clinical applications.生长激素在生育和不育中的作用:作用机制及临床应用。
Front Endocrinol (Lausanne). 2022 Nov 14;13:1040503. doi: 10.3389/fendo.2022.1040503. eCollection 2022.
3
Effects of growth hormone co-treatment on in vitro fertilization outcomes in women with expected normal ovarian response.
生长激素联合治疗对预期卵巢反应正常的女性体外受精结局的影响。
Turk J Obstet Gynecol. 2021 Dec 24;18(4):285-290. doi: 10.4274/tjod.galenos.2021.03439.
4
Growth hormone for in vitro fertilisation (IVF).促性腺激素在体外受精(IVF)中的应用。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD000099. doi: 10.1002/14651858.CD000099.pub4.
5
Human growth hormone use in poor ovarian response - caution and opportunities.生长激素在卵巢低反应中的应用——注意事项与机遇
Ther Adv Reprod Health. 2021 Mar 19;15:2633494121999420. doi: 10.1177/2633494121999420. eCollection 2021 Jan-Dec.
6
Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve.生长激素在卵巢储备功能低下女性体外受精治疗中的应用。
Front Endocrinol (Lausanne). 2019 Jul 24;10:500. doi: 10.3389/fendo.2019.00500. eCollection 2019.
7
Growth Hormone (GH) Improvement of Ovarian Responses and Pregnancy Outcome in Poor Ovarian Responders: A Randomized Study.生长激素(GH)对卵巢反应不良者卵巢反应及妊娠结局的改善作用:一项随机研究。
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2033-2037. doi: 10.31557/APJCP.2019.20.7.2033.
8
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.不同生长激素添加方案对卵巢反应不良者在控制性卵巢刺激周期中临床结局的影响:一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Mar;96(12):e6443. doi: 10.1097/MD.0000000000006443.
9
Growth hormone for in vitro fertilization.用于体外受精的生长激素。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000099. doi: 10.1002/14651858.CD000099.pub3.
10
Growth hormone cotreatment with gonadotropins in ovulation induction.在排卵诱导中生长激素与促性腺激素联合治疗。
J Endocrinol Invest. 1996 Dec;19(11):763-79. doi: 10.1007/BF03347881.